139 related articles for article (PubMed ID: 35587829)
1. Contrast-enhanced ultrasound of solid pancreatic head lesions: a prospective study.
Gupta P; Rana P; Marodia Y; Samanta J; Sharma V; Sinha SK; Singh H; Gupta V; Yadav TD; Sreenivasan R; Vaiphei K; Rajwanshi A; Kochhar R; Sandhu M
Eur Radiol; 2022 Oct; 32(10):6668-6677. PubMed ID: 35587829
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the diagnostic performance of the EFSUMB CEUS Pancreatic Applications guidelines (2017 version): a retrospective single-center analysis of 455 solid pancreatic masses.
Jia WY; Gui Y; Chen XQ; Zhang XQ; Zhang JH; Dai MH; Guo JC; Chang XY; Tan L; Bai CM; Cheng YJ; Li JC; Lv K; Jiang YX
Eur Radiol; 2022 Dec; 32(12):8485-8496. PubMed ID: 35699767
[TBL] [Abstract][Full Text] [Related]
3. Nonhypovascular pancreatic ductal adenocarcinomas: CEUS imaging findings and differentiation from other types of solid pancreatic lesions.
Wang L; Nie F; Dong T; Yin C; Li M; Li Y
Clin Hemorheol Microcirc; 2022; 81(2):163-176. PubMed ID: 35253738
[TBL] [Abstract][Full Text] [Related]
4. Role of contrast-enhanced ultrasound with time-intensity curve analysis for differentiating hypovascular solid pancreatic lesions.
Wang L; Nie F; Dong T; Li M; Li Y; Yin C
Eur Radiol; 2023 Jul; 33(7):4885-4894. PubMed ID: 36725721
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of contrast-enhanced ultrasound enhancement patterns for differentiating solid pancreatic lesions.
Wang Y; Li G; Yan K; Fan Z; Long R; Shan J; Dai Y; Wu W
Eur Radiol; 2022 Mar; 32(3):2060-2069. PubMed ID: 34716476
[TBL] [Abstract][Full Text] [Related]
6. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
[TBL] [Abstract][Full Text] [Related]
7. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Qiu YJ; Zhao GC; Shi SN; Zuo D; Zhang Q; Dong Y; Lou WH; Wang WP
Clin Hemorheol Microcirc; 2022; 81(2):149-161. PubMed ID: 35253737
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced ultrasound for diagnosing, staging and assessment of operability of pancreatic cancer.
Grossjohann HS
Dan Med J; 2012 Dec; 59(12):B4536. PubMed ID: 23290292
[TBL] [Abstract][Full Text] [Related]
9. [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].
Wu L; Guo W; Li Y; Cheng T; Yao Y; Zhang Y; Liu B; Zhong M; Li S; Deng X; Zhu W
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1171-1178. PubMed ID: 30377133
[TBL] [Abstract][Full Text] [Related]
10. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography.
Kitano M; Kudo M; Yamao K; Takagi T; Sakamoto H; Komaki T; Kamata K; Imai H; Chiba Y; Okada M; Murakami T; Takeyama Y
Am J Gastroenterol; 2012 Feb; 107(2):303-10. PubMed ID: 22008892
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound diagnosis of pancreatic solid tumors.
Sofuni A; Tsuchiya T; Itoi T
J Med Ultrason (2001); 2020 Jul; 47(3):359-376. PubMed ID: 31420821
[TBL] [Abstract][Full Text] [Related]
12. Differential diagnosis of solid pancreatic lesions using contrast-enhanced three-dimensional ultrasonography.
Miwa H; Numata K; Sugimori K; Kaneko T; Sakamaki K; Ueda M; Fukuda H; Tanaka K; Maeda S
Abdom Imaging; 2014 Oct; 39(5):988-99. PubMed ID: 24711063
[TBL] [Abstract][Full Text] [Related]
13. CEUS of the pancreas: Still research or the standard of care.
D'Onofrio M; Canestrini S; De Robertis R; Crosara S; Demozzi E; Ciaravino V; Pozzi Mucelli R
Eur J Radiol; 2015 Sep; 84(9):1644-9. PubMed ID: 25796427
[TBL] [Abstract][Full Text] [Related]
14. Contrast-Enhanced Ultrasound for differential diagnosis of pancreatic mass lesions: a meta-analysis.
Lin LZ; Li F; Liu Y; Xing LX; Du LF
Med Ultrason; 2016 Jun; 18(2):163-9. PubMed ID: 27239649
[TBL] [Abstract][Full Text] [Related]
15. Transabdominal contrast-enhanced ultrasonography of pancreatic cancer.
Kersting S; Roth J; Bunk A
Pancreatology; 2011; 11 Suppl 2():20-7. PubMed ID: 21464583
[TBL] [Abstract][Full Text] [Related]
16. Contrast-Enhanced Ultrasonography of Pancreatic Carcinoma: Correlation with Pathologic Findings.
Wang Y; Yan K; Fan Z; Sun L; Wu W; Yang W
Ultrasound Med Biol; 2016 Apr; 42(4):891-8. PubMed ID: 26806440
[TBL] [Abstract][Full Text] [Related]
17. Contrast enhanced transabdominal ultrasound in the characterisation of pancreatic lesions with cystic appearance.
Beyer-Enke SA; Hocke M; Ignee A; Braden B; Dietrich CF
JOP; 2010 Sep; 11(5):427-33. PubMed ID: 20818109
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of contrast-enhanced ultrasound (CEUS) and contrast-enhanced endoscopic ultrasound (ECEUS) for the differentiation of pancreatic lesions: a systematic review and meta-analysis.
D'Onofrio M; Biagioli E; Gerardi C; Canestrini S; Rulli E; Crosara S; De Robertis R; Floriani I
Ultraschall Med; 2014 Dec; 35(6):515-21. PubMed ID: 25226455
[TBL] [Abstract][Full Text] [Related]
19. Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions--a comparison of conventional ultrasound and contrast-enhanced CT.
Fan Z; Li Y; Yan K; Wu W; Yin S; Yang W; Xing B; Li X; Zhang X
Eur J Radiol; 2013 Sep; 82(9):1385-90. PubMed ID: 23727375
[TBL] [Abstract][Full Text] [Related]
20. Contrast enhanced ultrasound versus multiphasic contrast enhanced computed tomography in evaluation of gallbladder lesions.
Boddapati SB; Lal A; Gupta P; Kalra N; Yadav TD; Gupta V; Dass A; Srinivasan R; Singhal M
Abdom Radiol (NY); 2022 Feb; 47(2):566-575. PubMed ID: 34874479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
